| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REPORT
CALL FOR PAPERS
Physiology and Pharmacology of Temperature Regulation
1Systemic Inflammation Laboratory, Trauma Research, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; and 2Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina
Submitted 26 May 2005 ; accepted in final form 28 July 2005
ABSTRACT
Previous studies on the role of cyclooxygenase (COX)-1 and -2 in fever induced by intravenous LPS have failed to investigate the role of these isoenzymes in the earliest responses: monophasic fever (response to a low, near-threshold dose of LPS) and the first phase of polyphasic fever (response to higher doses). We studied these responses in 96 mice that were COX-1 or COX-2 deficient (–/–) or sufficient (+/+). Each mouse was implanted with a temperature telemetry probe into the peritoneal cavity and a jugular catheter. The study was conducted at a tightly controlled, neutral ambient temperature (31°C). To avoid stress hyperthermia (which masks the onset of fever), all injections were performed through a catheter extension. The +/+ mice responded to intravenous saline with no change in deep body temperature. To a low dose of LPS (1 µg/kg iv), they responded with a monophasic fever. To a higher dose (56 µg/kg), they responded with a polyphasic fever. Neither monophasic fever nor the first phase of polyphasic fever was attenuated in the COX-1 –/– mice, but both responses were absent in the COX-2 –/– mice. The second and third phases of polyphasic fever were also missing in the COX-2 –/– mice. The present study identifies a new, critical role for COX-2 in the mediation of the earliest responses to intravenous LPS: monophasic fever and the first phase of polyphasic fever. It also suggests that no product of the COX-1 gene, including the splice variant COX-1b (COX-3), is essential for these responses.
prostaglandin E2; cyclooxygenase-1b; cyclooxygenase-1V1; cyclooxygenase-3; prostaglandin H2 synthase; body temperature; thermoregulation; febrile phases
This article has been cited by other articles:
|
|
 |
|
  A. A. Steiner, J. C. Hunter, S. M. Phipps, T. B. Nucci, D. L. Oliveira, J. L. Roberts, A. C. Scheck, D. L. Simmons, and A. A. Romanovsky Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia? Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R485 - R494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Havird, M. M. Miyamoto, K. P. Choe, and D. H. Evans Gene Duplications and Losses within the Cyclooxygenase Family of Teleosts and Other Chordates Mol. Biol. Evol., November 1, 2008; 25(11): 2349 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ootsuka, W. W. Blessing, A. A. Steiner, and A. A. Romanovsky Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1294 - R1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. DiMicco and D. V. Zaretsky The dorsomedial hypothalamus: a new player in thermoregulation Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R47 - R63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Romanovsky Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R37 - R46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Persson Temperature control: from molecular insights, regulation in king penguins and diving seals, to studies in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R512 - R514. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
